2011 HPTN Presentations at the

6th IAS Conference on HIV Pathogenesis, Treatment and Prevention

17-20 July 2011 Rome, Italy

 

Monday, 18 July 2011

 

Title Authors Presenter

Session:  Reaching the Hard to Reach with Testing
Reaching out to men in Soweto through a community-based VCT approach (HPTN 043) G. Robertson, S. Mhlongo, M. Van der Watt, G. Gray Gavin Robertson

Session:  Treatment as Prevention: The Proof is Here
Antiretroviral treatment to prevent the sexual transmission of HIV-1: results from the HPTN 052 multinational randomized controlled trial M. Cohen, Y. Chen, M. McCauley, T. Gamble, R. Bollinger, Y. Bryson, D. Burns, D. Celentano, S. Chariyalertsak, F. Conradie, L. Cottle, G. de Bruyn, V. Elharrar, S. Eshelman, M. Essex, E.C.J. Filho, S. Godbole, B. Grinsztejn, J.G. Hakim, I.F. Hoffman, M. Hosseinipour, N. Kumarasamy, J. Kumwenda, J. Makhema, A. Martinez, K.H. Mayer, S. Mehendale, L.A. Mills, K.A.-H. Nielsen, J.H.d.S. Pilotto, E. Piwowar-Manning, I. Sanne, B.R. Santos, T. Taha, L. Wang, S. Safren, T. Fleming, HPTN052 Protocol Team Myron Cohen
Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network (HPTN) 052 trial J. Hughes, S. Hudelson, A. Redd, L. Wang, R. Debes, Y. Chen, S. Porcella, E. Piwowar-Manning, M. McCauley, M. Hosseinipour, J. Kumwenda, J. Hakim, S. Chariyalertsak, G. de Bruyn, B. Grinsztejn, N. Kumarasamy, J. Makhema, K. Mayer, J. Pilotto, B. Santos, T. Quinn, M. Cohen, S. Eshleman, HPTN 052 Susan Eshleman
Immunologic and virologic disease progression and responses to ART across geographic regions: outcomes from HPTN 052 study M.C. Hosseinipour, L. Wang, M.S. Cohen, S. Chariyalertsak, Y.Q. Chen, V. Elharrar, S. Eshleman, J. Gallant, T. Gamble, S. Godbole, S. Govinder, B. Grinsztejn, J.G. Hakim, D. Havlir, P. Ive, K. Klingman, N. Kumarasamy, J. Kumwenda, J. Makhema, K. Mayer, M. McCauley, L. Mills, J. Pilotto, E. Piwowar-Manning, H. Ribaudo, B.R. Santos, S. Swindells, J.J. Eron, and the HPTN 052 study team Mina Hosseinipour
Effects of early versus delayed initiation of antiretroviral therapy (ART) on HIV clinical outcomes: results from the HPTN 052 randomized clinical trial

 

 B. Grinsztejn, H. Ribaudo, M.S. Cohen, S. Swindells, S. Badel-Faesen, D. Burns, S. Chariyalertsak, Y.Q. Chen, G. de Bruyn, J.J. Eron, S. Eshleman, T. Fleming, J. Gallant, T. Gamble, S.V. Godbole, J.G. Hakim, M.C. Hosseinipour, K. Klingman, N. Kumarasamy, J. Kumwenda, J. Makhema, K.H. Mayer, M. McCauley, L.A. Mills, J.H. Pilotto, E. Piwowar-Manning, B.R. Santos, L. Wang, D. Havlir, HPTN 052 Protocol Team

 

 Beatriz Grinsztejn
HPTN 052 Summary M.S. Cohen Myron Cohen

 

 

Tuesday, July 19, 2011

 

Title Authors Presenter

Session:  Prevention for Most At-Risk Populations

School-based interventions

 A. Pettifor Audrey Pettifor
Multilevel determinants of women’s HIV risk in the United States: qualitative implications for intervention development from the HIV Prevention Trial Network’s (HPTN) Women’s HIV SeroIncidence Study (ISIS) (HPTN 064) P.M. Frew, C. del Rio, A. O'Leary, I. Kuo, J. Justman, D. Haley, W. Chege, C. Golin, A. Adimora, C. Root, H. Waller, L. Jones, K. Lancaster, J. Lucas, A. Amsterdam, S. Hodder, for the HIV Prevention Trials Network Women’s HIV SeroIncidence Study (ISIS) Team Paula M. Frew